Digital Health has moved beyond experimentation, yet many pharmaceutical companies still struggle to turn its potential into value at scale. Our white paper “Bridging the Value Gap: Turning Digital Health Promise into Enterprise Impact” explores how pharma can address this gap by focusing Digital Health on key business and patient challenges.
Drawing on insights from industry roundtables with Digital Health leaders from Bristol Myers Squibb and Pfizer, the paper provides practical approaches to making Digital Health more strategic, integrated and scalable, including actions leaders can start within the next 90 days.
